Trevena Announces Pricing of $50 Million Public Offering of Common Stock

Aug 12, 2020 9:27am EDT

Trevena Announces Proposed Public Offering of Common Stock

Aug 11, 2020 4:01pm EDT

Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection

Aug 10, 2020 6:30am EDT

Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.

Jun 03, 2020 8:02am EDT

Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients

Jun 02, 2020 7:00am EDT

Trevena Reports First Quarter 2020 Results

May 07, 2020 7:00am EDT

Trevena to Release First Quarter 2020 Financial Results on May 7, 2020

May 01, 2020 7:00am EDT

Trevena Announces Publication of Comprehensive Review of Oliceridine Data

Apr 23, 2020 7:00am EDT

Trevena Reports Fourth Quarter and Full Year 2019 Results

Mar 12, 2020 7:01am EDT

Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020

Mar 05, 2020 5:00pm EST